The facility has been treating vulnerable populations, including Sudanese refugees who are fleeing the conflict in their home country
Dr Khayat is representing DuBiotech at the 10th International Conference on Thalassaemia and Hemoglobinopathies, being held in conjunction with the 12th International TIF Conference for Thalassaemia Patients and Parents at Dubai World Trade Centre.
Speaking to Khaleej Times, he said that thalassaemia is a major disease in the UAE with one in 20 persons being affected in the region.
“DuBiotech’s initiative at the conference is to promote biotechnology in the UAE. We are also negotiating with different international organisations and companies to create awareness about the disease and set up a centre in the UAE. DuBiotech aims at enhancing research in the region, fostering biotechnology education, providing training and industry support, offering highly developed multi-faceted infrastructure and facilities and presenting a knowledge-based bio-economy for the region," said Dr Khayat.
"The spread of the disease in the region is because of inter-marriages, and the only treatment available is gene therapy," he said.
Dr Khayat also offered his condolences on the death of Shaikh Maktoum bin Rashid Al Maktoum.
The facility has been treating vulnerable populations, including Sudanese refugees who are fleeing the conflict in their home country
Six buildings were levelled in the initial wave of strikes and according to a preliminary toll, six people were killed and 91 wounded
A perfect meal should strike a balance between protein, whole grains, fruits, vegetables, and healthy fats
Temperatures may reach a high of 40 degrees Celsius in Abu Dhabi and 37 degrees Celsius in Dubai
Being recognised as a major defence partner was a welcome development that mirrored a confidence in US policy, says Sheikh Abdullah bin Zayed
Institutions also conduct psychometric tests in secondary years to help guide future career choices
Originally from New Zealand, Steve Ashby formed ‘Rise,’ a community-driven initiative aimed at raising awareness and supporting those affected
Cardiologists recommend that healthy adults undergo cardiac checks every two to four years, particularly those 40 years old and above